436-37938-20969
3 vaccinations
3 coded responses
35 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-07-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-20
Dose 1 — Pfizer-BioNTech
-
2021-07-22
Registered in v-safe
- 2021-07-22
- 2021-07-23
- 2021-07-24
- 2021-07-25
- 2021-07-26
- 2021-07-27
- 2021-08-03
-
2021-08-10
Dose 2 — Pfizer-BioNTech
- 2021-08-10
- 2021-08-11
- 2021-08-12
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-24
- 2021-08-31
- 2021-09-07
- 2021-09-14
- 2021-09-21
- 2021-11-09
-
2022-01-15
Dose 3 — Moderna
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-21
- 2022-01-22
- 2022-01-29
- 2022-02-05
- 2022-02-14
- 2022-02-19
-
2022-02-26
Survey response — day 42, dose 3MedDRA: Nasopharyngitis, Oropharyngeal pain, Sneezing — Feeling: GoodFree text: Sore throat, sneezing cold like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Survey response — 3 months, dose 3MedDRA: Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Sore throat, headache, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-17
Survey response — 6 months, dose 3MedDRA: Costochondritis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: costochondritisMedDRA releases: 2024-11 · check-in free text available
-
2022-07-17
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-20 | Pfizer-BioNTech | No |
| 2 | 2021-08-10 | Pfizer-BioNTech | No |
| 3 | 2022-01-15 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-17 | Unsuccessful |
Free text
Release 11 — day 42, dose 3
Symptoms: Sore throat, sneezing cold like symptoms
Release 11 — 3 months, dose 3
Symptoms: Sore throat, headache, runny nose
Release 12 — 6 months, dose 3
Symptoms: costochondritis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Costochondritis | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release